Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026
Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 11.90 +0.39 (3.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.51 | 52 Week High | $34.49 | |||
| Open | $11.48 | 52 Week Low | $20.39 | |||
| Day High | $12.10 | P/E | N/A | |||
| Day Low | $11.11 | EPS | $-3.18 | |||
| Volume | 190,272 | |||||

